Evidence map›Paper›PMID 24772314›Full record

ArticleMolecular and clinical oncology2014

Next-generation sequencing of

Lubomir Balabanski, Georgi Antov, Ivanka Dimova, Samuil Ivanov, Maria Nacheva, Ivan Gavrilov, Desislava Nesheva, Blaga Rukova, Savina Hadjidekova, Maxim Malinov and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Molecular and clinical oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Lubomir BalabanskiGenomic Laboratory, Malinov Hospital, 1680 Sofia;
Georgi AntovBulgarian Academy of Sciences, Institute of Genetics 'Academician Doncho Kostov', 1113 Sofia;
Ivanka DimovaDepartment of Medical Genetics, Medical University of Sofia, 1431 Sofia;
Samuil IvanovGenomic Laboratory, Malinov Hospital, 1680 Sofia;
Maria NachevaSpecialized Hospital for Active Treatment in Oncology, 1756 Sofia, Bulgaria.
Ivan GavrilovSpecialized Hospital for Active Treatment in Oncology, 1756 Sofia, Bulgaria.
Desislava NeshevaDepartment of Medical Genetics, Medical University of Sofia, 1431 Sofia;
Blaga RukovaDepartment of Medical Genetics, Medical University of Sofia, 1431 Sofia;
Savina HadjidekovaDepartment of Medical Genetics, Medical University of Sofia, 1431 Sofia;
Maxim MalinovGenomic Laboratory, Malinov Hospital, 1680 Sofia;
Draga TonchevaGenomic Laboratory, Malinov Hospital, 1680 Sofia; ; Department of Medical Genetics, Medical University of Sofia, 1431 Sofia;
Medical University of Sofia · BGNational Institute of Genomic Medicine · MXUniversity Specialized Hospital for Active Treatment of Endocrinology · BGBulgarian Academy of Sciences · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is currently the most common type of cancer in females. The majority of the hereditary forms of breast cancer are caused by mutations in the

Indexed as

BRCA1/BRCA2 next-generation sequencingbreast cancerhereditary predisposition

Identifiers

PMID24772314
PMCPMC3999126
OpenAlexW2148105015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.